Echo Therapeutics Reports Results of Diabetes Study

Echo Therapeutics, Inc., a company developing … a non-invasive, wireless, transdermal continuous glucose monitoring system …, announced positive results of a clinical study of its Symphony tCGM System in patients with Type 1 and Type 2 Diabetes.
Canadian Business